Dr. Dale Corbett
A Memorial University research project aimed at preventing cognitive impairment is among Canadian projects being renewed through the Canadian Institutes of Health Research (CIHR) and Canada’s Research-Based Pharmaceutical Companies (Rx&D) Collaborative Research Program.
Dr. Dale Corbett, Canada Research Chair in Stroke and Neuroplasticity, is examining whether keeping the body and mind active can help keep our brains fit. Dr. Corbett is identifying molecular mechanisms, such as changes in brain growth factors that help physical exercise and cognitive activity maintain brain health. This knowledge will facilitate the development of new therapies to prevent or slow age-related cognitive decline.
Over the past five years, the program has invested over $320 million in research projects at universities and teaching hospitals across Canada, making this the largest and most successful public-private health research program in the country. The objective of the CIHR/Rx&D Collaborative Research Program focuses on building clinical research support through personnel awards such as CIHR-Rx&D Research Chairs and operating support programs, including research grants and clinical trials.
The program, which has been in existence for more than 15 years, also encourages the sharing of best practices in clinical research, leading to better training of investigators and more comprehensive clinical trials.
These activities reflect an ongoing commitment to research and the creation of new and innovative ideas, ideas critical to improved health and Canada’s competitiveness in the global knowledge-based economy.
For more information, visit: http://www.mun.ca/research/chairs/corbett.php